-
Sep 30, 2024 | 
jdsupra.com | Sarah Bouchard |Scott Memmott |Sandra Moser
The Criminal Division of the US Department of Justice released a revised version of its Evaluation of Corporate Compliance Programs on September 23, 2024. The guidance is intended to help prosecutors assess the effectiveness of corporate compliance programs during a criminal investigation. Principal Deputy Assistant Attorney General Nicole M.
-
Sep 24, 2024 | 
morganlewis.com | Michael Abernathy |Stephen Altieri |Louis W. Beardell |Jacqueline R. Berman |Olga Berson |Christopher J. Betti | +23 more
NEW YORK, September 24, 2024: Morgan Lewis has received 13 practice rankings and 27 individual lawyer recognitions in the 2024 edition of Legal Media Group’s (LMG) LMG Life Sciences guide, an annual guide that honors law firms and lawyers for outstanding work in life sciences.
-
Jul 29, 2024 | 
jdsupra.com | Scott Memmott |Jonathan York
At the end of last year, the US Department of Health and Human Services Office of Inspector General (OIG) issued an Advisory Opinion (AO 23-11, the Opinion) in which OIG approved an arrangement where a medical device manufacturer would provide up to $2,000 in subsidies to Medicare beneficiaries for cost sharing obligations as part of the beneficiary’s participation in a clinical trial.
-
Jul 26, 2024 | 
morganlewis.com | Jonathan York |Scott Memmott
At the end of last year, the US Department of Health and Human Services Office of Inspector General (OIG) issued an Advisory Opinion (AO 23-11, the Opinion) in which OIG approved an arrangement where a medical device manufacturer would provide up to $2,000 in subsidies to Medicare beneficiaries for cost sharing obligations as part of the beneficiary’s participation in a clinical trial.
-
May 10, 2024 | 
jdsupra.com | Scott Memmott |Jonathan York
The Boston Bar Association hosted its fifth annual White Collar Crime Conference on May 2, 2024, featuring prosecutors from the US Attorney’s Office for the District of Massachusetts (the Office) and the Office of the Massachusetts Attorney General (the AG’s Office) as well as lawyers from the defense bar.
-
May 9, 2024 | 
morganlewis.com | Jonathan York |Scott Memmott
The Boston Bar Association hosted its fifth annual White Collar Crime Conference on May 2, 2024, featuring prosecutors from the US Attorney’s Office for the District of Massachusetts (the Office) and the Office of the Massachusetts Attorney General (the AG’s Office) as well as lawyers from the defense bar.
-
Feb 23, 2024 | 
morganlewis.com | Jacob Harper |Kathleen McDermott |Scott Memmott |Meredith Auten
The US Department of Justice (DOJ) Civil Division released its annual fraud statistics on February 22, highlighted by False Claims Act (FCA) settlements and judgments exceeding $2.68 billion in fiscal year 2023. DOJ released these annual fraud statistics, detailing its wins in the prior fiscal year, in conjunction with remarks delivered by DOJ Principal Deputy Assistant Attorney General Brian Boynton at the Federal Bar Association Qui Tam Section Conference.
-
Feb 16, 2024 | 
jdsupra.com | Rachel Lamparelli |Scott Memmott
New York expanded its existing efforts at monitoring and understanding prescription drug prices by enacting legislation addressing prescription drug price transparency. Effective June 19, 2024, S.599-A/A.1707 amends the New York Insurance Law to require prescription drug manufacturers to report certain price increases before they occur.
-
Feb 15, 2024 | 
lexology.com | Rachel Lamparelli |Scott Memmott
New York expanded its existing efforts at monitoring and understanding prescription drug prices by enacting legislation addressing prescription drug price transparency. Effective June 19, 2024, S.599-A/A.1707 amends the New York Insurance Law to require prescription drug manufacturers to report certain price increases before they occur.
-
Feb 15, 2024 | 
morganlewis.com | Rachel Lamparelli |Scott Memmott
New York expanded its existing efforts at monitoring and understanding prescription drug prices by enacting legislation addressing prescription drug price transparency. Effective June 19, 2024, S.599-A/A.1707 amends the New York Insurance Law to require prescription drug manufacturers to report certain price increases before they occur.
